NCT01712789 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 682
- units
- Participants
- groups
- description
- Participants received 4 mg pomalidomide (POM) by mouth (PO) on Days 1 to 21 of each 28-day treatment cycle and low dose dexamethasone (LD-Dex) PO at the starting dose of 40 mg/day (≤ 75 years old) or 20 mg/day (\> 75 years old) on Days 1, 8, 15 and 22 of a 28-day cycle until the documentation of confirmed progressive disease (PD), intolerable toxicity, death, withdrawal of participation in the study/consent, lost to follow-up, or as long as they benefited from therapy according to the opinion of the responsible study investigator.
- id
- BG000
- title
- Pomalidomide Plus Low Dose Dexamethasone (LD-Dex)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.10
- value
- 65.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 301
- title
- Female
- measurements
- group Id
- BG000
- value
- 381
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 52
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 626
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 4
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 669
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- title
- Other
- measurements
- group Id
- BG000
- value
- 4
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 295
- title
- 0 = Fully active, no restrictions
- measurements
- group Id
- BG000
- value
- 319
- title
- 1 = Restricted activity but ambulatory
- measurements
- group Id
- BG000
- value
- 67
- title
- 2 = Ambulatory and capable of all self-care
- measurements
- group Id
- BG000
- value
- 1
- title
- 3 = Limited self-care
- measurements
- group Id
- BG000
- value
- 0
- title
- 4 = Completely disabled
- description
- ECOG performance status is used to describe a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). The scale ranges from 0 to 5: 0 = Fully active, no restrictions; 1 = Restricted activity but ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out work activities; 3 = Limited self-care, confined to bed or chair more than 50% of waking hours; 4 = Completely disabled, no self-care, confined to bed or chair; 5 = Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.649
- value
- 6.15
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time since diagnosis
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 4.713
- value
- 5.48
- description
- This test measures the amount of a protein called beta-2 microglobulin (B2M) in the blood.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Beta 2 Microglobulin
- unit Of Measure
- mg/L
- classes
- categories
- measurements
- group Id
- BG000
- value
- 364
- title
- Kappa
- measurements
- group Id
- BG000
- value
- 230
- title
- Lambda
- measurements
- group Id
- BG000
- value
- 16
- title
- No Serum Light chain Type Detected
- measurements
- group Id
- BG000
- value
- 72
- title
- Test Not Performed
- description
- Light chains are proteins made by plasma cells and make immunoglobulins (antibodies). Immunoglobulins help protect the body against illness and infections. Immunoglobulins are formed when light chains link up with heavy chains, another type of protein. There are two types of light chains: lambda and kappa light chains. A free light chains test measures the amount of lambda and kappa free light chains in the blood. If the amount of free light chains is higher or lower than normal, it can mean you have a disorder of the plasma cells.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Serum Light Chain Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- Immunoglobulin A (IgA)
- measurements
- group Id
- BG000
- value
- 5
- title
- Immunoglobulin D (IgD)
- measurements
- group Id
- BG000
- value
- 0
- title
- Immunoglobulin E (IgE)
- measurements
- group Id
- BG000
- value
- 388
- title
- Immunoglobulin G (IgG)
- measurements
- group Id
- BG000
- value
- 4
- title
- Immunoglobulin M (IgM)
- measurements
- group Id
- BG000
- value
- 68
- title
- No serum heavy chain type detected
- measurements
- group Id
- BG000
- value
- 72
- title
- Test not performed
- description
- Immunoglobulins help protect the body against illness and infections. Immunoglobulins are formed when light chains link up with heavy chains, another type of protein.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Serum Heavy Chain Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- < 30 mL/min
- measurements
- group Id
- BG000
- value
- 57
- title
- 30 - < 45 mL/min
- measurements
- group Id
- BG000
- value
- 168
- title
- 45 - < 60 mL/min
- measurements
- group Id
- BG000
- value
- 190
- title
- 60 - < 80 mL/min
- measurements
- group Id
- BG000
- value
- 250
- title
- ≥ 80 mL/min
- measurements
- group Id
- BG000
- value
- 5
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Renal Function (Cockcroft Gault Creatinine Clearance)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.231
- value
- 2.43
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Corrected Serum Calcium
- unit Of Measure
- mmol/L
- population Description
- The intent to treat (ITT) population was defined as all enrolled participants (participants who received an interactive voice response system (IVRS) enrollment date) regardless of whether they received any investigational product (IP) or not.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 682
- units
- Participants
- groups
- description
- Participants received 4 mg pomalidomide (POM) by mouth (PO) on Days 1 to 21 of each 28-day treatment cycle and low dose dexamethasone (LD-Dex) PO at the starting dose of 40 mg/day (≤ 75 years old) or 20 mg/day (\> 75 years old) on Days 1, 8, 15 and 22 of a 28-day cycle until the documentation of confirmed progressive disease (PD), intolerable toxicity, death, withdrawal of participation in the study/consent, lost to follow-up, or as long as they benefited from therapy according to the opinion of the responsible study investigator.
- id
- BG000
- title
- Pomalidomide Plus Low Dose Dexamethasone (LD-Dex)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.10
- value
- 65.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 301
- title
- Female
- measurements
- group Id
- BG000
- value
- 381
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 52
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 626
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Asian
- measurements
- group Id
- BG000
- value
- 4
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 669
- title
- White
- measurements
- group Id
- BG000
- value
- 2
- title
- Other
- measurements
- group Id
- BG000
- value
- 4
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 295
- title
- 0 = Fully active, no restrictions
- measurements
- group Id
- BG000
- value
- 319
- title
- 1 = Restricted activity but ambulatory
- measurements
- group Id
- BG000
- value
- 67
- title
- 2 = Ambulatory and capable of all self-care
- measurements
- group Id
- BG000
- value
- 1
- title
- 3 = Limited self-care
- measurements
- group Id
- BG000
- value
- 0
- title
- 4 = Completely disabled
- description
- ECOG performance status is used to describe a patient's level of functioning in terms of their ability to care for themselves, daily activity, and physical ability (walking, working, etc.). The scale ranges from 0 to 5: 0 = Fully active, no restrictions; 1 = Restricted activity but ambulatory, able to carry out work of a light nature; 2 = Ambulatory and capable of all self-care but unable to carry out work activities; 3 = Limited self-care, confined to bed or chair more than 50% of waking hours; 4 = Completely disabled, no self-care, confined to bed or chair; 5 = Dead
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 3.649
- value
- 6.15
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Time since diagnosis
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 4.713
- value
- 5.48
- description
- This test measures the amount of a protein called beta-2 microglobulin (B2M) in the blood.
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Beta 2 Microglobulin
- unit Of Measure
- mg/L
- classes
- categories
- measurements
- group Id
- BG000
- value
- 364
- title
- Kappa
- measurements
- group Id
- BG000
- value
- 230
- title
- Lambda
- measurements
- group Id
- BG000
- value
- 16
- title
- No Serum Light chain Type Detected
- measurements
- group Id
- BG000
- value
- 72
- title
- Test Not Performed
- description
- Light chains are proteins made by plasma cells and make immunoglobulins (antibodies). Immunoglobulins help protect the body against illness and infections. Immunoglobulins are formed when light chains link up with heavy chains, another type of protein. There are two types of light chains: lambda and kappa light chains. A free light chains test measures the amount of lambda and kappa free light chains in the blood. If the amount of free light chains is higher or lower than normal, it can mean you have a disorder of the plasma cells.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Serum Light Chain Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- Immunoglobulin A (IgA)
- measurements
- group Id
- BG000
- value
- 5
- title
- Immunoglobulin D (IgD)
- measurements
- group Id
- BG000
- value
- 0
- title
- Immunoglobulin E (IgE)
- measurements
- group Id
- BG000
- value
- 388
- title
- Immunoglobulin G (IgG)
- measurements
- group Id
- BG000
- value
- 4
- title
- Immunoglobulin M (IgM)
- measurements
- group Id
- BG000
- value
- 68
- title
- No serum heavy chain type detected
- measurements
- group Id
- BG000
- value
- 72
- title
- Test not performed
- description
- Immunoglobulins help protect the body against illness and infections. Immunoglobulins are formed when light chains link up with heavy chains, another type of protein.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Serum Heavy Chain Type
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- title
- < 30 mL/min
- measurements
- group Id
- BG000
- value
- 57
- title
- 30 - < 45 mL/min
- measurements
- group Id
- BG000
- value
- 168
- title
- 45 - < 60 mL/min
- measurements
- group Id
- BG000
- value
- 190
- title
- 60 - < 80 mL/min
- measurements
- group Id
- BG000
- value
- 250
- title
- ≥ 80 mL/min
- measurements
- group Id
- BG000
- value
- 5
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Renal Function (Cockcroft Gault Creatinine Clearance)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.231
- value
- 2.43
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Corrected Serum Calcium
- unit Of Measure
- mmol/L
- population Description
- The intent to treat (ITT) population was defined as all enrolled participants (participants who received an interactive voice response system (IVRS) enrollment date) regardless of whether they received any investigational product (IP) or not.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle